HEGPOL: randomized, placebo controlled, multicenter, double-blind clinical trial to investigate hepatoprotective effects of glycine in the postoperative phase of liver transplantation [ISRCTN69350312].
Luntz, Steffen P
HEGPOL: randomized, placebo controlled, multicenter, double-blind clinical trial to investigate hepatoprotective effects of glycine in the postoperative phase of liver transplantation [ISRCTN69350312]. [electronic resource] - BMC surgery Aug 2005 - 18 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1471-2482
10.1186/1471-2482-5-18 doi
Alanine Transaminase--metabolism
Aspartate Aminotransferases--metabolism
Clinical Protocols
Cyclosporine--adverse effects
Cytoprotection--drug effects
Double-Blind Method
Glycine--administration & dosage
Glycine Agents--administration & dosage
Kidney Diseases--chemically induced
Kupffer Cells--drug effects
Liver Transplantation--mortality
Multicenter Studies as Topic
Postoperative Care
Randomized Controlled Trials as Topic--methods
Reperfusion Injury--diagnosis
Research Design
Survival Rate
HEGPOL: randomized, placebo controlled, multicenter, double-blind clinical trial to investigate hepatoprotective effects of glycine in the postoperative phase of liver transplantation [ISRCTN69350312]. [electronic resource] - BMC surgery Aug 2005 - 18 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1471-2482
10.1186/1471-2482-5-18 doi
Alanine Transaminase--metabolism
Aspartate Aminotransferases--metabolism
Clinical Protocols
Cyclosporine--adverse effects
Cytoprotection--drug effects
Double-Blind Method
Glycine--administration & dosage
Glycine Agents--administration & dosage
Kidney Diseases--chemically induced
Kupffer Cells--drug effects
Liver Transplantation--mortality
Multicenter Studies as Topic
Postoperative Care
Randomized Controlled Trials as Topic--methods
Reperfusion Injury--diagnosis
Research Design
Survival Rate